SCHEMBL22017933

SCHEMBL22017933

CC(C)N1CC(=O)N(O)C(=O)C1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.34
ALDH1A1 P00352 3/20 0.34
TDP1 Q9NUW8 2/20 0.34
TOP2A P11388 1/20 0.34
TOP2B Q02880 1/20 0.34
EGFR P00533 1/20 0.34
PTK2 Q05397 1/20 0.34
MMP1 P03956 3/20 0.33
MMP2 P08253 3/20 0.33
MMP3 P08254 3/20 0.33
MMP9 P14780 3/20 0.33
MMP8 P22894 3/20 0.33
MMP12 P39900 3/20 0.33
MMP13 P45452 3/20 0.33
MMP14 P50281 3/20 0.33
MMP16 P51512 3/20 0.33
ADAM17 P78536 3/20 0.33
MMP7 P09237 1/20 0.33
SMN1; SMN2 Q16637 3/20 0.33
KDM4E B2RXH2 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12534603 0.77 ALDH1A1 (0.36) MAPTALDH1A1TDP1TOP2ATOP2B
SCHEMBL14959575 0.77 SMN1; SMN2 (0.37) MAPTALDH1A1TDP1TOP2ATOP2B
SCHEMBL11930002 0.71 EGFR (0.33) MAPTALDH1A1TDP1TOP2ATOP2B
SCHEMBL12187921 0.71 F2 (0.40) MAPTALDH1A1TDP1TOP2ATOP2B
SCHEMBL17898508 0.69 ALDH1A1 (0.37) MAPTALDH1A1TDP1TOP2ATOP2B
SCHEMBL12415723 0.68 PIK3CD (0.39) MAPTALDH1A1TDP1TOP2ATOP2B
SCHEMBL19459067 0.67
SCHEMBL7848559 0.67 PIK3CD (0.52) MAPTALDH1A1TDP1TOP2ATOP2B
SCHEMBL12040692 0.67 P2RX7 (0.39) MAPTALDH1A1TDP1TOP2ATOP2B
SCHEMBL12706200 0.67 TSHR (0.36) MAPTALDH1A1TDP1TOP2ATOP2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11332485-B2 Penicillin-binding protein inhibitors VenatoRx Pharmaceuticals, Inc. (US) 2022-05-17 US disclosed
US-20210198288-A1 PENICILLIN-BINDING PROTEIN INHIBITORS VenatoRx Pharmaceuticals, Inc. 2021-07-01 US disclosed
US-20200157123-A1 PENICILLIN-BINDING PROTEIN INHIBITORS NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2020-05-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200157123-A1 PENICILLIN-BINDING PROTEIN INHIBITORS PEPD, BPGM, EBPL MAPT 3146/4885ALDH1A1 2794/4885TDP1 1223/4885
US-20210198288-A1 PENICILLIN-BINDING PROTEIN INHIBITORS PEPD, BPGM, EBPL MAPT 3146/4885ALDH1A1 2794/4885TDP1 1223/4885
US-11332485-B2 Penicillin-binding protein inhibitors PEPD, BPGM, EBPL MAPT 3146/4885ALDH1A1 2794/4885TDP1 1223/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.